{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:18:00Z","timestamp":1760955480012},"reference-count":77,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurologic.theclinics.com","mdconsult.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.ncl.2014.04.002","type":"journal-article","created":{"date-parts":[[2014,5,9]],"date-time":"2014-05-09T21:16:38Z","timestamp":1399670198000},"page":"801-815","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Muscle Channelopathies"],"prefix":"10.1016","volume":"32","author":[{"given":"Jeffrey","family":"Statland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaya R.","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib1","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1046\/j.1523-1755.2000.00915.x","article-title":"Molecular mechanisms of ion conduction in ClC-type chloride channels: lessons from disease-causing mutations","volume":"57","author":"Fahlke","year":"2000","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0960-8966(91)90039-U","article-title":"Population frequencies of inherited neuromuscular diseases\u2013a world survey","volume":"1","author":"Emery","year":"1991","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF02043311","article-title":"Myotonia congenita and myotonic dystrophy: descriptive epidemiological investigation in Turin, Italy (1955-1979)","volume":"3","author":"Pinessi","year":"1982","journal-title":"Ital J Neurol Sci"},{"key":"10.1016\/j.ncl.2014.04.002_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1146\/annurev.neuro.29.051605.112815","article-title":"Pathomechanisms in channelopathies of skeletal muscle and brain","volume":"29","author":"Cannon","year":"2006","journal-title":"Annu Rev Neurosci"},{"issue":"Pt 12","key":"10.1016\/j.ncl.2014.04.002_bib5","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1093\/brain\/awm248","article-title":"Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions","volume":"130","author":"Fialho","year":"2007","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.ncl.2014.04.002_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/archneur.1993.00540110101010","article-title":"Duchenne-Becker muscular dystrophy and the nondystrophic myotonias. Paradigms for loss of function and change of function of gene products","volume":"50","author":"Hoffman","year":"1993","journal-title":"Arch Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib7","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S1071-9091(96)80041-6","article-title":"Channelopathies: the nondystrophic myotonias and periodic paralyses","volume":"3","author":"Lehmann-Horn","year":"1996","journal-title":"Semin Pediatr Neurol"},{"issue":"5","key":"10.1016\/j.ncl.2014.04.002_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/0092-8674(91)90374-8","article-title":"Identification of a mutation in the gene causing hyperkalemic periodic paralysis","volume":"67","author":"Ptacek","year":"1991","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ncl.2014.04.002_bib9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/sj.ejhg.5200736","article-title":"Spectrum of CLCN1 mutations in patients with myotonia congenita in Northern Scandinavia","volume":"9","author":"Sun","year":"2001","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijgo.2009.01.031","article-title":"Pregnancy in women with myotonia congenita","volume":"106","author":"Basu","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"10.1016\/j.ncl.2014.04.002_bib11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.nmd.2008.07.004","article-title":"Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita","volume":"18","author":"Fialho","year":"2008","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib12","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0303-8467(99)00019-0","article-title":"Fluctuating clinical myotonia and weakness from Thomsen's disease occurring only during pregnancies","volume":"101","author":"Lacomis","year":"1999","journal-title":"Clin Neurol Neurosurg"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib13","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.65.4.569","article-title":"Familial cramp due to potassium-aggravated myotonia","volume":"65","author":"Orrell","year":"1998","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"7","key":"10.1016\/j.ncl.2014.04.002_bib14","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1212\/WNL.0b013e3181ed9e96","article-title":"Severe neonatal episodic laryngospasm due to de novo SCN4A mutations: a new treatable disorder","volume":"75","author":"Lion-Francois","year":"2010","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib15","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mus.20295","article-title":"Phenotypic variability in myotonia congenita","volume":"32","author":"Colding-Jorgensen","year":"2005","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ncl.2014.04.002_bib16","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1097\/WCO.0b013e32833cc97e","article-title":"Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis","volume":"23","author":"Raja Rayan","year":"2010","journal-title":"Curr Opin Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2014.04.002_bib17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mus.880100704","article-title":"AAEE minimonograph #27: differential diagnosis of myotonic syndromes","volume":"10","author":"Streib","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.002_bib18","series-title":"Topics in human genetics","author":"Becker","year":"1977"},{"issue":"Pt 7","key":"10.1016\/j.ncl.2014.04.002_bib19","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1093\/brain\/awt133","article-title":"Non-dystrophic myotonia: prospective study of objective and patient reported outcomes","volume":"136","author":"Trivedi","year":"2013","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.ncl.2014.04.002_bib20","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/jnnp.2008.162396","article-title":"Redefining the clinical phenotypes of non-dystrophic myotonic syndromes","volume":"80","author":"Trip","year":"2009","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2014.04.002_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/brain\/awp294","article-title":"The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment","volume":"133","author":"Matthews","year":"2010","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.ncl.2014.04.002_bib22","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1212\/01.WNL.0000143383.91137.00","article-title":"Correlating phenotype and genotype in the periodic paralyses","volume":"63","author":"Miller","year":"2004","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.ncl.2014.04.002_bib23","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1056\/NEJM199302183280707","article-title":"Genetics and physiology of the myotonic muscle disorders","volume":"328","author":"Ptacek","year":"1993","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib24","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0960-8966(93)90001-Z","article-title":"Periodic paralysis, myotonia congenita and sarcolemmal ion channels: a success of the candidate gene approach","volume":"3","author":"Fontaine","year":"1993","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib25","first-page":"851","article-title":"Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus","volume":"49","author":"Ptacek","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib26","first-page":"378","article-title":"Analysis in a large hyperkalemic periodic paralysis pedigree supports tight linkage to a sodium channel locus","volume":"49","author":"Ptacek","year":"1991","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.ncl.2014.04.002_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/0896-6273(92)90203-P","article-title":"Mutations in an S4 segment of the adult skeletal muscle sodium channel cause paramyotonia congenita","volume":"8","author":"Ptacek","year":"1992","journal-title":"Neuron"},{"issue":"11","key":"10.1016\/j.ncl.2014.04.002_bib28","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1001\/archneur.1994.00540230033009","article-title":"Myotonia fluctuans. A third type of muscle sodium channel disease","volume":"51","author":"Ricker","year":"1994","journal-title":"Arch Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.37.3.488","article-title":"Acetazolamide-responsive myotonia congenita","volume":"37","author":"Trudell","year":"1987","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2014.04.002_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1136\/jnnp.41.11.1013","article-title":"Hypothyroidism with true myotonia","volume":"41","author":"Venables","year":"1978","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2014.04.002_bib31","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/ana.20241","article-title":"Electromyography guides toward subgroups of mutations in muscle channelopathies","volume":"56","author":"Fournier","year":"2004","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib32","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.20905","article-title":"Cold extends electromyography distinction between ion channel mutations causing myotonia","volume":"60","author":"Fournier","year":"2006","journal-title":"Ann Neurol"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2014.04.002_bib33","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1093\/brain\/awf246","article-title":"Novel CLCN1 mutations with unique clinical and electrophysiological consequences","volume":"125","author":"Wu","year":"2002","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1113\/jphysiol.1971.sp009667","article-title":"Chloride conductance in normal and myotonic muscle fibres and the action of monocarboxylic aromatic acids","volume":"219","author":"Bryant","year":"1971","journal-title":"J\u00a0Physiol"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1113\/jphysiol.1974.sp010620","article-title":"On the repetitive discharge in myotonic muscle fibres","volume":"240","author":"Adrian","year":"1974","journal-title":"J\u00a0Physiol"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/ng0493-305","article-title":"Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita)","volume":"3","author":"George","year":"1993","journal-title":"Nat Genet"},{"issue":"5071","key":"10.1016\/j.ncl.2014.04.002_bib37","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1379744","article-title":"The skeletal muscle chloride channel in dominant and recessive human myotonia","volume":"257","author":"Koch","year":"1992","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.ncl.2014.04.002_bib38","first-page":"2071","article-title":"Nonsense and missense mutations of the muscle chloride channel gene in patients with myotonia congenita","volume":"3","author":"George","year":"1994","journal-title":"Hum Mol Genet"},{"issue":"6","key":"10.1016\/j.ncl.2014.04.002_bib39","first-page":"1325","article-title":"Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN1) leading to myotonia","volume":"57","author":"Meyer-Kleine","year":"1995","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1212\/WNL.53.2.297","article-title":"Founder mutations and the high prevalence of myotonia congenita in northern Finland","volume":"53","author":"Papponen","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib41","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1212\/WNL.47.4.993","article-title":"Mutations in the human skeletal muscle chloride channel gene (CLCN1) associated with dominant and recessive myotonia congenita","volume":"47","author":"Zhang","year":"1996","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib42","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1085\/jgp.113.3.457","article-title":"The muscle chloride channel ClC-1 has a double-barreled appearance that is differentially affected in dominant and recessive myotonia","volume":"113","author":"Saviane","year":"1999","journal-title":"J\u00a0Gen Physiol"},{"issue":"6","key":"10.1016\/j.ncl.2014.04.002_bib43","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/0896-6273(95)90023-3","article-title":"Mutations in dominant human myotonia congenita drastically alter the voltage dependence of the CIC-1 chloride channel","volume":"15","author":"Pusch","year":"1995","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.ncl.2014.04.002_bib44","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/mus.880040508","article-title":"Membrane defects in paramyotonia congenita with and without myotonia in a warm environment","volume":"4","author":"Lehmann-Horn","year":"1981","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib45","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mus.880060206","article-title":"Two cases of adynamia episodica hereditaria: in\u00a0vitro investigation of muscle cell membrane and contraction parameters","volume":"6","author":"Lehmann-Horn","year":"1983","journal-title":"Muscle Nerve"},{"issue":"6","key":"10.1016\/j.ncl.2014.04.002_bib46","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/ana.410300610","article-title":"Paramyotonia congenita and hyperkalemic periodic paralysis are linked to the adult muscle sodium channel gene","volume":"30","author":"Ebers","year":"1991","journal-title":"Ann Neurol"},{"issue":"4983","key":"10.1016\/j.ncl.2014.04.002_bib47","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1126\/science.2173143","article-title":"Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene","volume":"250","author":"Fontaine","year":"1990","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.ncl.2014.04.002_bib48","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1001\/jama.2012.12607","article-title":"Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial","volume":"308","author":"Statland","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ncl.2014.04.002_bib49","series-title":"GeneReviews [Internet]","article-title":"Myotonia congenita","author":"Dun\u00f8","year":"2005"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0014-4886(85)90228-6","article-title":"Efficacy of phenytoin, procainamide, and tocainide in murine genetic myotonia","volume":"87","author":"Aichele","year":"1985","journal-title":"Exp Neurol"},{"issue":"6","key":"10.1016\/j.ncl.2014.04.002_bib51","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/0002-8703(85)90373-4","article-title":"Tocainide associated agranulocytosis","volume":"109","author":"Volosin","year":"1985","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib52","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00228-012-1414-3","article-title":"Dramatic improvement of myotonia permanens with flecainide: a two-case report of a possible bench-to-bedside pharmacogenetics strategy","volume":"69","author":"Desaphy","year":"2013","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/(SICI)1097-4598(200001)23:1<138::AID-MUS23>3.0.CO;2-4","article-title":"Response to carbamazepine of recessive-type myotonia congenita","volume":"23","author":"Berardinelli","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.002_bib54","series-title":"Neuromuscular disorders in clinical practice","first-page":"987","article-title":"Disorders of skeletal muscle membrane excitability: myotonia congenita, paramyotonia congenita, periodic paralysis, and related disorders","author":"Shapiro","year":"2002"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib55","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/mus.23320","article-title":"Role of disease severity, illness perceptions, and mood on quality of life in muscle disease","volume":"46","author":"Rose","year":"2012","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.ncl.2014.04.002_bib56","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/j.1468-1331.2012.03751.x","article-title":"Measuring quality of life impairment in skeletal muscle channelopathies","volume":"19","author":"Sansone","year":"2012","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/brain\/82.1.81","article-title":"The treatment of myotonia: a controlled clinical trial","volume":"82","author":"Leyburn","year":"1959","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(75)90319-8","article-title":"Cardiac conduction in myotonic dystrophy","volume":"59","author":"Griggs","year":"1975","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0404.1992.tb05103.x","article-title":"Treatment of myotonia with antiarrhythmic drugs","volume":"86","author":"Kwiecinski","year":"1992","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.ncl.2014.04.002_bib60","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1196\/annals.1254.016","article-title":"Congenital myasthenic syndromes: multiple molecular targets at the neuromuscular junction","volume":"998","author":"Engel","year":"2003","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib61","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.nurt.2007.01.001","article-title":"The therapy of congenital myasthenic syndromes","volume":"4","author":"Engel","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib62","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ana.410430411","article-title":"Quinidine sulfate therapy for the slow-channel congenital myasthenic syndrome","volume":"43","author":"Harper","year":"1998","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2014.04.002_bib63","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/mus.23534","article-title":"Slow channel congenital myasthenic syndrome responsive to a combination of fluoxetine and salbutamol","volume":"47","author":"Finlayson","year":"2013","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ncl.2014.04.002_bib64","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0065-2660(08)01001-8","article-title":"Periodic paralysis","volume":"63","author":"Fontaine","year":"2008","journal-title":"Adv Genet"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.cell.2009.12.024","article-title":"Mutations in potassium channel Kir2.6 cause susceptibility to thyrotoxic hypokalemic periodic paralysis","volume":"140","author":"Ryan","year":"2010","journal-title":"Cell"},{"issue":"Pt 1","key":"10.1016\/j.ncl.2014.04.002_bib66","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/brain\/awh639","article-title":"The primary periodic paralyses: diagnosis, pathogenesis and treatment","volume":"129","author":"Venance","year":"2006","journal-title":"Brain"},{"issue":"16","key":"10.1016\/j.ncl.2014.04.002_bib67","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1212\/WNL.0b013e31828cf8d0","article-title":"Prevalence study of genetically defined skeletal muscle channelopathies in England","volume":"80","author":"Horga","year":"2013","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib68","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/mus.880060303","article-title":"Treatment of \u201cpermanent\u201d muscle weakness in familial Hypokalemic Periodic Paralysis","volume":"6","author":"Dalakas","year":"1983","journal-title":"Muscle Nerve"},{"issue":"Pt 6","key":"10.1016\/j.ncl.2014.04.002_bib69","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1093\/brain\/113.6.1873","article-title":"Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects","volume":"113","author":"Links","year":"1990","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.ncl.2014.04.002_bib70","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0092-8674(01)00342-7","article-title":"Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome","volume":"105","author":"Plaster","year":"2001","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.ncl.2014.04.002_bib71","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1172\/JCI15183","article-title":"Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome)","volume":"110","author":"Tristani-Firouzi","year":"2002","journal-title":"J\u00a0Clin Invest"},{"issue":"Pt 11","key":"10.1016\/j.ncl.2014.04.002_bib72","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1113\/jphysiol.2010.186874","article-title":"Voltage-sensor mutations in channelopathies of skeletal muscle","volume":"588","author":"Cannon","year":"2010","journal-title":"J\u00a0Physiol"},{"issue":"10","key":"10.1016\/j.ncl.2014.04.002_bib73","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1172\/JCI57398","article-title":"A\u00a0sodium channel knockin mutant (NaV1.4-R669H) mouse model of hypokalemic periodic paralysis","volume":"121","author":"Wu","year":"2011","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.ncl.2014.04.002_bib74","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1172\/JCI66091","article-title":"A\u00a0calcium channel mutant mouse model of hypokalemic periodic paralysis","volume":"122","author":"Wu","year":"2012","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005045.pub2","article-title":"Treatment for periodic paralysis","author":"Sansone","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.ncl.2014.04.002_bib76","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1531-8249(200001)47:1<46::AID-ANA9>3.0.CO;2-H","article-title":"Randomized trials of dichlorphenamide in the periodic paralyses. Working Group on Periodic Paralysis","volume":"47","author":"Tawil","year":"2000","journal-title":"Ann Neurol"},{"issue":"13","key":"10.1016\/j.ncl.2014.04.002_bib77","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1001\/jama.2012.12906","article-title":"Mexiletine for treatment of myotonia: a trial triumph for rare disease networks","volume":"308","author":"Hoffman","year":"2012","journal-title":"JAMA"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861914000255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,10]],"date-time":"2019-08-10T10:19:10Z","timestamp":1565432350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861914000255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":77,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0733861914000255"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2014.04.002","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle Channelopathies","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2014.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}